Role of soluble epoxide hydrolase in age-related vascular cognitive decline

Jonathan W. Nelson, Jennifer M. Young, Rohan N. Borkar, Randy L. Woltjer, Joseph F. Quinn, Lisa C. Silbert, Marjorie R. Grafe, Nabil J. Alkayed

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

P450 eicosanoids are important regulators of the cerebral microcirculation, but their role in cerebral small vessel disease is unclear. We tested the hypothesis that vascular cognitive impairment (VCI) is linked to reduced cerebral microvascular eicosanoid signaling. We analyzed human brain tissue from individuals formerly enrolled in the Oregon Brain Aging Study, who had a history of cognitive impairment histopathological evidence of microvascular disease. VCI subjects had significantly higher lesion burden both on premortem MRI and postmortem histopathology compared to age- and sex-matched controls. Mass spectrometry-based eicosanoid analysis revealed that 14,15-dihydroxyeicosatrienoic acid (DHET) was elevated in cortical brain tissue from VCI subjects. Immunoreactivity of soluble epoxide hydrolase (sEH), the enzyme responsible for 14,15-DHET formation, was localized to cerebral microvascular endothelium, and was enhanced in microvessels of affected tissue. Finally, we evaluated the genotype frequency of two functional single nucleotide polymorphisms of sEH gene EPHX2 in VCI and control groups. Our findings support a role for sEH and a potential benefit from sEH inhibitors in age-related VCI.

Original languageEnglish (US)
Pages (from-to)30-37
Number of pages8
JournalProstaglandins and Other Lipid Mediators
Volume113-115
DOIs
StatePublished - Sep 30 2014

    Fingerprint

Keywords

  • EETs
  • EPHX2
  • Epoxyeicosatrienoic acids
  • Soluble epoxide hydrolase
  • Vascular cognitive impairment
  • White matter hyperintensity

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Pharmacology
  • Cell Biology

Cite this